ADGI
Adagio Therapeutics, Inc.
Set alert
4.64 0.00 0.00%
4.40 Day range 4.74
52-week range unavailable
- Open
- 4.62
- Prev close
- 4.64
- Mkt cap
- 504.98M
- Vol
- 535.00K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.40
- High
- 4.74
- Forward P/E
- -2.34
- Beta
- 0.00
- Short ratio
- 8.85
- Inst. own
- 71.59%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 15, 2022
- 50-d avg
- 4.18
- 200-d avg
- 4.78
- 1y target
- 3.83
Financial health
Altman Z-Score
2.31 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -15.5×
FY 2021 5y median -3.6× FY 2025
P/S 15.0×
FY 2021 5y median 15.0× FY 2025
P/B 3.3×
FY 2021 5y median 3.3× FY 2025
P/FCF -13.7×
FY 2021 5y median -4.4× FY 2025
EV/EBITDA 273×
FY 2021 5y median 155× FY 2025
EV/Sales 10.8×
FY 2021 5y median 10.8× FY 2025
FCF Yield -7.3%
FY 2021 5y median -22.9% FY 2025
Profitability
Gross Margin 93.0%
FY 2021 5y median 93.0% FY 2025
Operating Margin -104.0%
FY 2021 5y median -104.0% FY 2025
Net Margin -98.2%
FY 2021 5y median -98.2% FY 2025
ROE -21.7%
FY 2021 5y median -40.6% FY 2025
ROIC -22.8%
FY 2021 5y median -40.9% FY 2025
ROA -19.0%
FY 2021 5y median -36.8% FY 2025
Growth (YoY)
Revenue 110.5%
FY 2021 FY 2025
Operating Income 68.6%
FY 2021 FY 2025
EPS (diluted) 79.0%
FY 2021 FY 2025
Free Cash Flow 65.8%
FY 2021 FY 2025
Financial Health
Current Ratio 7.2×
FY 2021 5y median 7.2× FY 2025
Quick Ratio 6.5×
FY 2021 5y median 6.5× FY 2025
Debt / Equity 0.0×
FY 2021 5y median 0.0× FY 2025
Net Debt / EBITDA -106×
FY 2021 5y median -21.9× FY 2025
Interest Coverage 0.0×
FY 2021 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31